Genertec Universal Medical Group Company Limited (02666) disclosed its monthly return for the period ending 30 November 2025. The total number of issued ordinary shares rose from 1,891,539,661 as of the end of October to 2,014,204,924, reflecting an increase of 122,665,263 shares.
According to the announcement, the new shares resulted from the conversion of US$90 million in convertible bonds by Dragonland International Development Limited at a conversion price of HKD5.70 per share. Following this conversion, the principal amount of the convertible bonds was reduced to zero, and 122,665,263 ordinary shares were issued on 12 November 2025. It was also confirmed that there were no share options outstanding under the company’s share option scheme as of the end of November 2025.
Comments